The L.A. Times reports that for the first time since 2007, the FDA has approved a weight loss device (as opposed to a weight-loss drug), an implantable device called the Maestro Rechargeable System. Using electrical leads implanted just above the stomach and a regulator carried under the skin near the ribcage, the device suppresses signals carried by the vagus nerve. … The device adopts a variant of a “neuromodulation” technique long used in the treatment of epilepsy: by applying intermittent bursts of electrical current to the vagus nerve, it disrupts the signals that prompt the stomach to relax, expand and prepare for an influx of food. … The FDA approved the use of the device in adult patients with a body mass index, or BMI, between 35 and 45, who have at least one other obesity-related condition, such as type 2 diabetes. Read more of this story at Slashdot.
Read the original:
FDA Approves Implantable Vagus Nerve Disruptor For Weight Loss
